Summary:

- This article reports the findings of a study that investigated the potential therapeutic effects of psilocybin, the psychoactive compound found in certain mushrooms, on individuals with major depressive disorder.
- The study involved a randomized, double-blind, placebo-controlled clinical trial with 233 participants, who were given either a single dose of psilocybin or a placebo in combination with psychological support.
- The results showed that a single dose of psilocybin, when combined with psychological support, was more effective in reducing depressive symptoms compared to the placebo, and the effects were sustained for up to 12 weeks, suggesting that psilocybin could be a promising treatment option for major depressive disorder.